Dolhun became interested in oral rehydration therapy while he was in Guatemala during a cholera outbreak in 1993.[2][3] Dolhun began developing the DripDrop formula in 2007[6] and finalized it in 2010.[7] Dolhun tested oral rehydration therapy mixtures of sugars and salts on his patients at his private practice, Dolhun Clinic, in San Francisco, California.[2][3] DripDrop received US Patent #8557301 in 2013.[8]
Funding rounds raised $3 million in August 2013[9][3] and $5.6 million in August 2014.[10][11][12][13]
DripDrop won the bronze in the "treatments" category of the Edison Awards in 2014.[14]
Philanthropy
Proceeds from sales of DripDrop support the company's philanthropic efforts.[13][15]
DripDrop ORS is designed to promote rehydration and electrolyte replacement in ill children, based on the American Academy of Pediatrics (AAP) Committee on Nutrition requirements to help prevent dehydration in infants and children. The product is similar to rehydration fluids used by the World Health Organization[25][26] that are used to treat illnesses such as cholera and rotavirus.
This page is based on this Wikipedia article Text is available under the CC BY-SA 4.0 license; additional terms may apply. Images, videos and audio are available under their respective licenses.